These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10677754)

  • 1. Parasitological cure of Chagas disease: is it possible? Is it relevant?
    Urbina JA
    Mem Inst Oswaldo Cruz; 1999; 94 Suppl 1():349-55. PubMed ID: 10677754
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of nifurtimox treatment of chronic Chagas disease by means of several parasitological methods.
    Muñoz C; Zulantay I; Apt W; Ortiz S; Schijman AG; Bisio M; Ferrada V; Herrera C; Martínez G; Solari A
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4518-23. PubMed ID: 23836179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can a killer be arrested?
    Kierszenbaum F
    Nat Med; 1996 Oct; 2(10):1071-2. PubMed ID: 8837597
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy of Trypanosoma cruzi infections.
    Brener Z
    Adv Pharmacol Chemother; 1975; 13():1-81. PubMed ID: 812348
    [No Abstract]   [Full Text] [Related]  

  • 5. The urgent need to develop new drugs and tools for the treatment of Chagas disease.
    Muñoz MJ; Murcia L; Segovia M
    Expert Rev Anti Infect Ther; 2011 Jan; 9(1):5-7. PubMed ID: 21171870
    [No Abstract]   [Full Text] [Related]  

  • 6. Cure of short- and long-term experimental Chagas' disease using D0870.
    Urbina JA; Payares G; Molina J; Sanoja C; Liendo A; Lazardi K; Piras MM; Piras R; Perez N; Wincker P; Ryley JF
    Science; 1996 Aug; 273(5277):969-71. PubMed ID: 8688084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose of benznidazole promotes therapeutic cure in experimental chronic Chagas' disease with absence of parasitism in blood, heart and colon.
    Perin L; Fonseca KDS; de Carvalho TV; Carvalho LM; Madeira JV; Medeiros LDF; Molina I; Correa-Oliveira R; Carneiro CM; Vieira PMA
    Exp Parasitol; 2020 Mar; 210():107834. PubMed ID: 31978394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies.
    Sguassero Y; Cuesta CB; Roberts KN; Hicks E; Comandé D; Ciapponi A; Sosa-Estani S
    PLoS One; 2015; 10(10):e0139363. PubMed ID: 26436678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined use of ascorbic acid and cyanocobalamin in clearance of Trypanosoma cruzi.
    Ghobadifar MA; Kalani N; Gitiforouz M
    Expert Rev Clin Pharmacol; 2014 Jul; 7(4):401-2. PubMed ID: 24857404
    [No Abstract]   [Full Text] [Related]  

  • 10. Recent clinical trials for the etiological treatment of chronic chagas disease: advances, challenges and perspectives.
    Urbina JA
    J Eukaryot Microbiol; 2015; 62(1):149-56. PubMed ID: 25284065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chagas Disease: A Solvable Problem, Ignored.
    Tarleton RL
    Trends Mol Med; 2016 Oct; 22(10):835-838. PubMed ID: 27523778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Criteria of Chagas disease cure.
    Cançado JR
    Mem Inst Oswaldo Cruz; 1999; 94 Suppl 1():331-5. PubMed ID: 10677750
    [No Abstract]   [Full Text] [Related]  

  • 13. Curcumin Enhances the Anti-Trypanosoma cruzi Activity of Benznidazole-Based Chemotherapy in Acute Experimental Chagas Disease.
    Novaes RD; Sartini MV; Rodrigues JP; Gonçalves RV; Santos EC; Souza RL; Caldas IS
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3355-64. PubMed ID: 27001816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacies of TAK-187, a long-lasting ergosterol biosynthesis inhibitor, and benznidazole in preventing cardiac damage in a murine model of Chagas' disease.
    Corrales M; Cardozo R; Segura MA; Urbina JA; Basombrío MA
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1556-60. PubMed ID: 15793138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chagas Disease and Coumarins: A Review of Natural and Synthetic Coumarins As Anti-Trypanosoma Cruzi Agents.
    Gonçalves GA; Cerecetto H; Poser GLV; Canto RFS; Eifler-Lima VL
    Mini Rev Med Chem; 2021; 21(13):1701-1717. PubMed ID: 33372872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parasitological cure in children infected with Trypanosoma cruzi.
    Leony LM; Santos FLN
    Lancet Infect Dis; 2021 Aug; 21(8):1058-1059. PubMed ID: 33836160
    [No Abstract]   [Full Text] [Related]  

  • 17. In Vitro Image-Based Assay for Trypanosoma cruzi Intracellular Forms.
    Eufrásio AG; Cordeiro AT
    Methods Mol Biol; 2020; 2116():773-780. PubMed ID: 32221954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited Ability of Posaconazole To Cure both Acute and Chronic Trypanosoma cruzi Infections Revealed by Highly Sensitive In Vivo Imaging.
    Francisco AF; Lewis MD; Jayawardhana S; Taylor MC; Chatelain E; Kelly JM
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4653-61. PubMed ID: 26014936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity.
    Zingales B; Miles MA; Moraes CB; Luquetti A; Guhl F; Schijman AG; Ribeiro I; ;
    Mem Inst Oswaldo Cruz; 2014 Sep; 109(6):828-33. PubMed ID: 25317712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new chemotype with promise against Trypanosoma cruzi.
    Wang X; Cal M; Kaiser M; Buckner FS; Lepesheva GI; Sanford AG; Wallick AI; Davis PH; Vennerstrom JL
    Bioorg Med Chem Lett; 2020 Jan; 30(1):126778. PubMed ID: 31706668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.